HK Stock MarketDetailed Quotes
08189 TEDA BIOMEDICAL
- 0.075
- 0.0000.00%
Market Closed Apr 26 16:08 CST
142.09MMarket Cap-6250P/E (TTM)
0.000High0.000Low0Volume0.075Open0.075Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)1.89BShares0.10552wk High2.59P/B89.78MFloat Cap0.06152wk Low--Dividend TTM1.20BShs Float1.950Historical High--Dividend LFY0.00%Amplitude0.058Historical Low--Avg Price5000Lot Size--Div YieldTTM--Div Yield LFY
TEDA BIOMEDICAL Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 33.52%-17.61M | ---- | 40.91%-26.5M | ---- | 10.32%-44.84M | ---- | 43.70%-50M | ---- | 70.44%-88.82M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 67.21%-250.12K | ---- | -77.05%-762.8K | ---- | 48.18%-430.83K | ---- | -53.48%-831.4K | ---- | 62.56%-541.71K | ---- |
| Interest expense - adjustment | -4.97%6.08M | ---- | 17.09%6.4M | ---- | 234.19%5.47M | ---- | -64.71%1.64M | ---- | 67.82%4.64M | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | -151.64%-1M | ---- | -60.87%1.94M | ---- | 77.39%4.95M | ---- |
| Impairment and provisions: | 115.00%11.18M | --0 | -86.25%5.2M | --0 | 9.71%37.84M | --0 | -35.27%34.49M | --0 | -77.17%53.29M | --0 |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | --3.16M | ---- | ---- | ---- | --8.75M | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -51.67%1.04M | ---- |
| -Impairment of trade receivables (reversal) | 93.91%9.48M | ---- | -58.37%4.89M | ---- | -42.30%11.74M | ---- | 1.76%20.35M | ---- | 417.74%19.99M | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | -94.74%420K | ---- | 112.81%7.98M | ---- | --3.75M | ---- |
| -Other impairments and provisions | 442.54%1.71M | ---- | -98.60%314.63K | ---- | 265.26%22.52M | ---- | -68.77%6.17M | ---- | -91.31%19.75M | ---- |
| Revaluation surplus: | 99.58%-224 | --0 | 97.75%-52.73K | --0 | -469.13%-2.34M | --0 | -93.55%633.92K | --0 | 541.66%9.83M | --0 |
| -Other fair value changes | 99.58%-224 | ---- | 97.75%-52.73K | ---- | -469.13%-2.34M | ---- | -93.55%633.92K | ---- | 541.66%9.83M | ---- |
| Asset sale loss (gain): | 103.36%196.77K | --0 | -3,686.53%-5.86M | --0 | 34.08%-154.77K | --0 | 88.70%-234.77K | --0 | -6,770.76%-2.08M | --0 |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---5.91M | ---- | ---- | ---- | ---- | ---- | ---1.92M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 285.05%196.77K | ---- | 133.02%51.1K | ---- | 34.08%-154.77K | ---- | -770.73%-234.77K | ---- | 10.85%-26.96K | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---132.07K | ---- |
| Depreciation and amortization: | -24.41%11.63M | --0 | 61.77%15.39M | --0 | 33.91%9.51M | --0 | -51.36%7.1M | --0 | -39.27%14.61M | --0 |
| -Depreciation | -27.08%10.94M | ---- | 60.40%15.01M | ---- | 37.40%9.36M | ---- | -48.95%6.81M | ---- | 89.52%13.34M | ---- |
| -Amortization of intangible assets | 80.60%689K | ---- | 143.59%381.5K | ---- | -46.75%156.62K | ---- | -76.77%294.11K | ---- | -92.43%1.27M | ---- |
| Special items | ---14.44M | ---- | ---- | ---- | ---- | ---- | -119.89%-296.59K | ---- | -88.59%1.49M | ---- |
| Operating profit before the change of operating capital | 48.06%-3.21M | --0 | -252.28%-6.18M | --0 | 172.99%4.06M | --0 | -111.15%-5.56M | --0 | 90.64%-2.63M | --0 |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -1,460.05%-16.55M | ---- | -92.59%1.22M | ---- | 706.13%16.42M | ---- | 46.50%-2.71M | ---- | 37.79%-5.06M | ---- |
| Accounts receivable (increase)decrease | 742.77%13.31M | ---- | -3,003.69%-2.07M | ---- | 101.66%71.33K | ---- | -65.78%-4.3M | ---- | -144.72%-2.59M | ---- |
| Accounts payable increase (decrease) | -1,151.56%-18.57M | ---- | 94.31%-1.48M | ---- | -192.42%-26.07M | ---- | 712.88%28.2M | ---- | 15.25%-4.6M | ---- |
| prepayments (increase)decrease | 151.30%2.69M | ---- | -133.86%-5.25M | ---- | 180.79%15.5M | ---- | -4,857.05%-19.18M | ---- | -115.42%-387.02K | ---- |
| Cash from business operations | 10.08%-7.11M | 116.83%3.1M | -520.39%-7.91M | -199.98%-18.43M | -103.36%-1.28M | 300.78%18.43M | 2,852.11%37.95M | 62.55%-9.18M | 106.23%1.29M | 20.23%-24.52M |
| Other taxs | -97.11%43.09K | 117.33%17.51K | 2,450.79%1.49M | -272.64%-101.02K | 117.65%58.51K | --58.51K | 26.03%-331.45K | ---- | -405.87%-448.08K | ---- |
| Interest received - operating | ---- | 40.77%392.41K | ---- | 6,165.77%278.76K | ---- | -94.79%4.45K | ---- | -87.94%85.47K | ---- | 8,391.47%708.53K |
| Interest paid - operating | 4.97%-6.08M | 52.84%-1.6M | -17.09%-6.4M | -541.31%-3.39M | -234.19%-5.47M | 43.92%-528.05K | 64.71%-1.64M | 7.22%-941.62K | -67.82%-4.64M | 44.02%-1.01M |
| Special items of business | 159.99%15.21M | ---- | 151.97%5.85M | ---- | -127.13%-11.26M | ---- | 150.57%41.5M | ---- | -23.89%16.56M | ---- |
| Net cash from operations | -2.60%-13.15M | 108.85%1.92M | -91.82%-12.82M | -220.43%-21.64M | -118.57%-6.68M | 279.02%17.97M | 1,047.41%35.99M | 59.57%-10.04M | 83.66%-3.8M | 24.52%-24.82M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -67.21%250.12K | ---- | 77.05%762.8K | ---- | -48.18%430.83K | ---- | 53.48%831.4K | ---- | -62.56%541.71K | ---- |
| Loan receivable (increase) decrease | ---- | ---- | -74.25%785.05K | ---- | -57.85%3.05M | ---- | 137.08%7.23M | ---- | --3.05M | ---- |
| Sale of fixed assets | --3K | ---- | ---- | ---- | 93.83%706.66K | ---- | 273.70%364.58K | ---- | 103.88%97.56K | ---- |
| Purchase of fixed assets | 71.94%-2.47M | 59.72%-1.29M | 68.12%-8.8M | -164.44%-3.2M | -350.95%-27.6M | -469.13%-1.21M | -393.53%-6.12M | 51.50%-212.49K | 86.25%-1.24M | 89.21%-438.13K |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | 22.83%-6.1M | ---- | ---7.9M | ---- | ---- | ---- |
| Sale of subsidiaries | ---- | ---- | --4.07M | ---- | ---- | ---- | ---- | ---- | ---86.65K | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---10.45M | ---- | ---- | ---- | ---- | ---- | ---2.65M | ---- |
| Recovery of cash from investments | 149.70%1.75M | ---- | -98.40%700K | ---- | 3,942.47%43.78M | ---- | -94.04%1.08M | ---- | --18.16M | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | -3.55%-22.78M | ---- | -144.44%-22M | ---- | -235.26%-9M | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 83.77%-81.13K |
| Net cash from investment operations | 96.38%-467.44K | 59.72%-1.29M | -51.93%-12.93M | -164.44%-3.2M | 67.90%-8.51M | -469.13%-1.21M | -398.87%-26.51M | 59.08%-212.49K | 149.26%8.87M | 88.54%-519.26K |
| Net cash before financing | 47.10%-13.62M | 102.52%626.92K | -69.48%-25.75M | -248.20%-24.84M | -260.36%-15.19M | 263.50%16.76M | 86.80%9.48M | 59.56%-10.25M | 112.30%5.07M | 32.27%-25.34M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 71.03%96.15M | 0.00%30M | 18.10%56.22M | --30M | 201.27%47.6M | ---- | -59.49%15.8M | 48.00%22.2M | -21.21%39M | -54.82%15M |
| Refund | -76.64%-82.7M | -13.64%-30M | -192.61%-46.82M | -654.29%-26.4M | 48.72%-16M | 85.66%-3.5M | 45.55%-31.2M | -39.43%-24.4M | -43.25%-57.3M | 15.46%-17.5M |
| Other items of the financing business | 77.68%-721.16K | ---- | 7.64%-3.23M | ---- | 26.98%-3.5M | ---- | 15.28%-4.79M | ---- | -125.05%-5.65M | ---- |
| Net cash from financing operations | 106.32%12.73M | --0 | -78.05%6.17M | 202.86%3.6M | 239.18%28.1M | -59.09%-3.5M | 15.71%-20.19M | 12.00%-2.2M | -151.20%-23.95M | -104.73%-2.5M |
| Net Cash | 95.44%-893.31K | 102.95%626.92K | -251.72%-19.58M | -260.17%-21.24M | 220.45%12.91M | 206.50%13.26M | 43.25%-10.72M | 55.29%-12.45M | -441.01%-18.88M | -280.93%-27.84M |
| Begining period cash | -74.07%6.86M | -74.07%6.86M | 95.38%26.44M | 95.38%26.44M | -44.19%13.53M | -44.13%13.53M | -43.78%24.25M | -43.85%24.22M | 14.73%43.13M | 14.73%43.13M |
| Cash at the end | -13.03%5.96M | 43.80%7.48M | -74.07%6.86M | -80.57%5.2M | 95.38%26.44M | 127.61%26.79M | -44.19%13.53M | -23.02%11.77M | -43.78%24.25M | -71.14%15.29M |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Fan Chen Certified Public Accountants Ltd | -- | Fan Chen Certified Public Accountants Ltd | -- | Fan Chen Certified Public Accountants Ltd | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg